Daiwa Securities Group Inc. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 98 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 6.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$20.0%2150.0%0.00%
Q2 2023$20.0%2150.0%0.00%
Q1 2023$20.0%2150.0%0.00%
Q4 2022$2
-99.9%
2150.0%0.00%
Q3 2022$2,0000.0%2150.0%0.00%
Q2 2022$2,0000.0%2150.0%0.00%
Q1 2022$2,0000.0%2150.0%0.00%
Q4 2021$2,000
+100.0%
215
+79.2%
0.00%
Q3 2021$1,000
-50.0%
1200.0%0.00%
Q2 2021$2,0000.0%1200.0%0.00%
Q1 2021$2,0000.0%1200.0%0.00%
Q4 2020$2,000
-60.0%
120
-65.5%
0.00%
Q3 2020$5,000
-84.4%
3480.0%0.00%
-100.0%
Q2 2020$32,000
+300.0%
3480.0%0.00%
Q1 2020$8,000
+14.3%
348
+8.8%
0.00%
Q4 2019$7,0000.0%320
-9.3%
0.00%
Q3 2019$7,000
+16.7%
3530.0%0.00%
Q2 2019$6,000
-25.0%
3530.0%0.00%
Q1 2019$8,000
-20.0%
353
+18.1%
0.00%
Q3 2018$10,000
+42.9%
2990.0%0.00%
Q2 2018$7,0000.0%2990.0%0.00%
Q1 2018$7,0002990.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$78,677,17613.94%
Irenic Capital Management LP 1,700,937$19,084,5139.15%
Weiss Asset Management LP 7,457,060$83,668,2133.41%
Newtyn Management, LLC 1,450,000$16,269,0003.36%
Palliser Capital (UK) Ltd 97,100$1,089,4622.65%
Chescapmanager LLC 850,988$9,5482.24%
Park West Asset Management LLC 1,920,324$21,546,0352.11%
Baupost Group 11,419,226$128,1242.09%
Saturn V Capital Management LP 141,339$1,334,3421.11%
Oasis Management Co Ltd. 296,960$3,331,8910.66%
View complete list of THERAVANCE BIOPHARMA INC shareholders